Post hoc analysis of the efficacy of pembrolizumab retreatment after progression of advanced urothelial carcinoma (UC) in KEYNOTE-045 and KEYNOTE-052.
Daniel E. Castellano,Arjun Vasant Balar,Peter H. O'Donnell,Petros Grivas,David J. Vaughn,Thomas Powles,Jacqueline Vuky,Jae-Lyun Lee,Yves Fradet,Joaquim Bellmunt,Miguel Angel Climent,Nicholas J. Vogelzang,Elizabeth R. Plimack,Howard Gurney,Noah M. Hahn,Cora N. Sternberg,Jin Zhi Xu,Kentaro Imai,Blanca Homet Moreno,Ronald De Wit JOURNAL OF CLINICAL ONCOLOGY（2022）
AI 理解论文
溯源树
样例
